Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study
Benjamin Greenberg, Brandon Brown, Elizabeth Camacho, Le H. Hua et al.
Journal
Journal of Neurology
Topics
Multiple Sclerosis Research Studies
article
Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study
Benjamin Greenberg, Brandon Brown, Elizabeth Camacho, Le H. Hua, Roland G. Henry, Enrique Álvarez, Ángel Chinea, Erik Houtsma, Natalie Moreo
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of NeurologyVol. 272(11)
Institutions
University of California, San Francisco (US), University of South Florida (US), Lou Ruvo Brain Institute (US), Novartis (United States) (US), Rocky Mountain MS Center (US), University of Colorado Anschutz Medical Campus (US), The University of Texas Southwestern Medical Center (US)